ELOS

COM:ELOSMEDTECH

Elos Medtech

  • Stock

SEK

Last Close

200.00

19/12 16:29

Market Cap

1.64B

Beta: -

Volume Today

10.32K

Avg: -

Company Overview

Metric
Company NameElos Medtech AB (publ)MedTech Careers
SymbolELOS-B
MSH IDCOM:ELOSMEDTECHDK:MEDTECHCAREERS
MarketSTOCKSPRIVATE
SectorHealthcareCommercial & Professional Services
IndustryMedical - Instruments & SuppliesHealthcare
CountrySEDK
Stage
Employee Count653
Websiteelosmedtech.commedtechcareers.dk
LinkedIn
Founders

Market Metrics

Metric
Market Cap148.39M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue80.64M
Revenue (LTM)
Revenue (NTM)
Gross Profit28.17M
EBITDA16.17M
Operating Income11.05M
Net Income6.81M
EPS0.84
Diluted EPS0.84
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.34
Operating Profit Margin0.12
EBITDA Margin0.20
Net Profit Margin0.05
Return on Equity0.07
Return on Assets0.04
Return on Capital Employed0.10

Valuation Multiples

Metric
P/E Ratio21.42
P/B Ratio2.08
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio1.61
EV Multiple9.02

Operational Metrics

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover0.65

Cash Flow Metrics

Metric
Operating Cash Flow9.83M
Free Cash Flow-812.58K
Cash Flow to Debt0.25
Operating Cash Flow/Sales0.09
Free Cash Flow Yield-0.01

Balance Sheet Metrics

Metric
Cash & Equivalents15.31M
Accounts Receivable-1.22M
Inventory20.91M
Goodwill26.39M
Debt to Capitalization0.33
Debt to Assets
Current Ratio1.99
Quick Ratio0.40

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue0.02
SG&A to Revenue0.14